Stock Earnings

Question 1

United Laboratories International Holdings Ltd'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, United Laboratories International Holdings Ltd'in toplam varlıkları $25,833 olup, net profit $2,659'dir.

Question 2

ULIHF'ün temel finansal oranları nelerdir?

Accepted Answer

United Laboratories International Holdings Ltd'in cari oranı 2.25, net kâr marjı 19.32, hisse başına satış $7.57'dir.

Question 3

United Laboratories International Holdings Ltd'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

United Laboratories International Holdings Ltd largest revenue segment is Bulk Medicine, at a revenue of 6,909,415,147 in the most earnings release.For geography, China, including Hong Kong is the primary market for United Laboratories International Holdings Ltd, at a revenue of 12,051,782,799.

Question 4

United Laboratories International Holdings Ltd kârlı mı?

Accepted Answer

yes, son mali tablolara göre United Laboratories International Holdings Ltd'in net profit $2,659'dir.

Question 5

United Laboratories International Holdings Ltd'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, United Laboratories International Holdings Ltd'in yükümlülüğü 11,444'dir.

Question 6

United Laboratories International Holdings Ltd'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

United Laboratories International Holdings Ltd'in toplam tedavüldeki hisse sayısı 1,817.02'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	14,101	13,758	13,739	11,334	9,703	8,772
Revenue Growth (YoY)	1%	0%	21%	17%	11%	5%
Cost of Revenue	7,439	7,676	7,405	6,365	5,492	4,966
Gross Profit	6,661	6,082	6,334	4,968	4,211	3,806
Selling, General & Admin	2,375	2,341	2,381	2,354	2,628	2,291
Research & Development	942	890	757	593	465	339
Operating Expenses	3,107	3,042	3,053	2,862	3,051	2,555
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	3,806	3,288	3,344	2,006	1,202	882
Income Tax Expense	746	631	643	425	213	181
Net Income	3,062	2,659	2,701	1,581	988	702
Net Income Growth	5%	-2%	71%	60%	41%	10%
Shares Outstanding (Diluted)	1,816.93	1,816.81	1,817.02	1,819.73	1,840.04	1,765.96
Shares Change (YoY)	0%	0%	0%	-1%	4%	8%
EPS (Diluted)	1.68	1.46	1.48	0.86	0.53	0.39
EPS Growth	5%	-2%	71%	62%	35%	2%
Free Cash Flow	--	1,329	1,028	1,212	1,060	1,037
Free Cash Flow Per Share	--	0.73	0.56	0.66	0.57	0.58
Gross Margin	47.23%	44.2%	46.1%	43.83%	43.39%	43.38%
Operating Margin	25.2%	22.08%	23.88%	18.58%	11.94%	14.24%
Profit Margin	21.71%	19.32%	19.65%	13.94%	10.18%	8%
Free Cash Flow Margin	--	9.65%	7.48%	10.69%	10.92%	11.82%
EBITDA	--	3,654	3,846	2,658	1,779	1,864
EBITDA Margin	--	26.55%	27.99%	23.45%	18.33%	21.24%
D&A For EBITDA	--	615	565	552	620	614
EBIT	3,554	3,039	3,281	2,106	1,159	1,250
EBIT Margin	25.2%	22.08%	23.88%	18.58%	11.94%	14.24%
Effective Tax Rate	19.6%	19.19%	19.22%	21.18%	17.72%	20.52%

United Laboratories International Holdings Ltd (ULIHF) Price

ULIHF Stock Price Chart

ULIHF Income

Follow-Up Questions